{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:48:39Z","timestamp":1790999319137,"version":"4.1.0"},"reference-count":149,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>The progressive myoclonus epilepsies (PME) are a diverse group of disorders that feature both myoclonus and seizures that worsen gradually over a variable timeframe. While each of the disorders is individually rare, they collectively make up a non-trivial portion of the complex epilepsy and myoclonus cases that are seen in tertiary care centers. The last decade has seen substantial progress in our understanding of the pathophysiology, diagnosis, prognosis, and, in select disorders, therapies of these diseases. In this scoping review, we examine English language publications from the past decade that address diagnostic, phenotypic, and therapeutic advances in all PMEs. We then highlight the major lessons that have been learned and point out avenues for future investigation that seem promising.<\/jats:p>","DOI":"10.3390\/genes15020171","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T08:11:27Z","timestamp":1706515887000},"page":"171","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Progressive Myoclonus Epilepsy: A Scoping Review of Diagnostic, Phenotypic and Therapeutic Advances"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5249-9427","authenticated-orcid":false,"given":"Vincent","family":"Zimmern","sequence":"first","affiliation":[{"name":"Division of Child Neurology, University of Texas Southwestern, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berge","family":"Minassian","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, University of Texas Southwestern, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/erm.2020.5","article-title":"Neuroinflammation and Progressive Myoclonus Epilepsies: From Basic Science to Therapeutic Opportunities","volume":"22","author":"Sanz","year":"2020","journal-title":"Expert. Rev. Mol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/NEN.0b013e31823e68e1","article-title":"Early Microglial Activation Precedes Neuronal Loss in the Brain of the Cstb\u2212\/\u2212 Mouse Model of Progressive Myoclonus Epilepsy, EPM1","volume":"71","author":"Tegelberg","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Joensuu, T., Tegelberg, S., Reinmaa, E., Segerstr\u00e5le, M., Hakala, P., Pehkonen, H., Korpi, E.R., Tyynel\u00e4, J., Taira, T., and Hovatta, I. (2014). Gene Expression Alterations in the Cerebellum and Granule Neurons of Cstb\u2212\/\u2212 Mouse Are Associated with Early Synaptic Changes and Inflammation. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089321"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12974-016-0764-7","article-title":"Brain Inflammation Is Accompanied by Peripheral Inflammation in Cstb\u2212\/\u2212 Mice, a Model for Progressive Myoclonus Epilepsy","volume":"13","author":"Okuneva","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s12035-019-01842-z","article-title":"Reactive Glia-Derived Neuroinflammation: A Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age","volume":"57","author":"Lahuerta","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1074\/mcp.RA119.001587","article-title":"Analysis of Brain and Cerebrospinal Fluid from Mouse Models of the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Changes in the Lysosomal Proteome","volume":"18","author":"Sleat","year":"2019","journal-title":"Mol. Cell. Proteom."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-018-0575-4","article-title":"Compromised Astrocyte Function and Survival Negatively Impact Neurons in Infantile Neuronal Ceroid Lipofuscinosis","volume":"6","author":"Lange","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1684\/epd.2016.0864","article-title":"Progressive Myoclonus Epilepsy: The Gene-Empowered Era","volume":"18","author":"Minassian","year":"2016","journal-title":"Epileptic Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44664","DOI":"10.1038\/srep44664","article-title":"Neurophysiological and BOLD Signal Uncoupling of Giant Somatosensory Evoked Potentials in Progressive Myoclonic Epilepsy: A Case-Series Study","volume":"7","author":"Storti","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.seizure.2015.05.006","article-title":"Blink Reflex in Progressive Myoclonic Epilepsies","volume":"29","author":"Kiziltan","year":"2015","journal-title":"Seizure"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1212\/NXG.0000000000000641","article-title":"Progressive Myoclonus Epilepsies: Diagnostic Yield with Next-Generation Sequencing in Previously Unsolved Cases","volume":"7","author":"Canafoglia","year":"2021","journal-title":"Neurol. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ajhg.2021.03.013","article-title":"Progressive Myoclonus Epilepsies\u2014Residual Unsolved Cases Have Marked Genetic Heterogeneity Including Dolichol-Dependent Protein Glycosylation Pathway Genes","volume":"108","author":"Courage","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1212\/WNL.0000000000000077","article-title":"Progressive Myoclonic Epilepsies: Definitive and Still Undetermined Causes","volume":"82","author":"Franceschetti","year":"2014","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"630366","DOI":"10.3389\/fneur.2021.630366","article-title":"Perampanel Improves Cortical Myoclonus and Disability in Progressive Myoclonic Epilepsies: A Case Series and a Systematic Review of the Literature","volume":"12","author":"Assenza","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/14737175.2020.1741350","article-title":"Emerging Treatments for Progressive Myoclonus Epilepsies","volume":"20","author":"Riva","year":"2020","journal-title":"Expert. Rev. Neurother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.2174\/1381612823666170809114654","article-title":"Update on Pharmacological Treatment of Progressive Myoclonus Epilepsies","volume":"23","author":"Ferlazzo","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e05324","DOI":"10.1016\/j.heliyon.2020.e05324","article-title":"Long-Term Outcomes of Two Patients with Progressive Myoclonic Epilepsy Treated with Vagus Nerve Stimulation Therapy","volume":"6","author":"Fujimoto","year":"2020","journal-title":"Heliyon"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1684\/epd.2016.0862","article-title":"Post-Modern Therapeutic Approaches for Progressive Myoclonus Epilepsy","volume":"18","author":"Minassian","year":"2016","journal-title":"Epileptic Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.seizure.2019.08.012","article-title":"The Best Evidence for Progressive Myoclonic Epilepsy: A Pathway to Precision Therapy","volume":"71","author":"Orsini","year":"2019","journal-title":"Seizure"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1684\/epd.2016.0841","article-title":"Unverricht-Lundborg Disease","volume":"18","author":"Crespel","year":"2016","journal-title":"Epileptic Disord."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1111\/epi.13626","article-title":"A Novel C132-134del Mutation in Unverricht-Lundborg Disease and the Review of Literature of Heterozygous Compound Patients","volume":"58","author":"Assenza","year":"2017","journal-title":"Epilepsia"},{"key":"ref_23","first-page":"87","article-title":"Unverricht-Lundborg Disease: Clinical Course and Seizure Management Based on the Experience of Polish Centers","volume":"69","author":"Lukasik","year":"2018","journal-title":"Seizure"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2020.01.014","article-title":"Automatic Assessment of the Myoclonus Severity from Videos Recorded According to Standardized Unified Myoclonus Rating Scale Protocol and Using Human Pose and Body Movement Analysis","volume":"76","author":"Hakala","year":"2020","journal-title":"Seizure"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.clinph.2021.06.026","article-title":"Wearable Monitoring of Positive and Negative Myoclonus in Progressive Myoclonic Epilepsy Type 1","volume":"132","author":"Rissanen","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1152\/jn.00063.2018","article-title":"Abnormal Motor Cortical Adaptation to External Stimulus in Unverricht-Lundborg Disease (Progressive Myoclonus Type 1, EPM1)","volume":"120","author":"Kallioniemi","year":"2018","journal-title":"J. Neurophysiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/epi.17466","article-title":"Short- and Long-Interval Intracortical Inhibition in EPM1 Is Related to Genotype","volume":"64","author":"Silvennoinen","year":"2023","journal-title":"Epilepsia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/ane.13706","article-title":"Comorbidities in Patients with Unverricht\u2013Lundborg Disease (EPM1)","volume":"146","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"ref_29","first-page":"E3117","article-title":"Unverricht-Lundborg Disease (EPM1) in Finland: A Nationwide Population-Based Study","volume":"95","year":"2020","journal-title":"Neurology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103459","DOI":"10.1016\/j.nicl.2023.103459","article-title":"Progressive Myoclonic Epilepsy Type 1 (EPM1) Patients Present with Abnormal 1H MRS Brain Metabolic Profiles Associated with Cognitive Function","volume":"39","author":"Paanila","year":"2023","journal-title":"Neuroimage Clin."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100551","DOI":"10.1016\/j.ebr.2022.100551","article-title":"FDG-PET Findings and Alcohol-Responsive Myoclonus in a Patient with Unverricht-Lundborg Disease","volume":"19","author":"Muccioli","year":"2022","journal-title":"Epilepsy Behav. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"108157","DOI":"10.1016\/j.yebeh.2021.108157","article-title":"Cognitive Functioning in Progressive Myoclonus Epilepsy Type 1 (Unverricht-Lundborg Disease, EPM1)","volume":"122","author":"Mervaala","year":"2021","journal-title":"Epilepsy Behav."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"100323","DOI":"10.1016\/j.ebr.2019.100323","article-title":"Autistic Features in Unverricht\u2013Lundborg Disease","volume":"12","author":"Tandon","year":"2019","journal-title":"Epilepsy Behav. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1684\/epd.2014.0654","article-title":"Seizure Control in Unverricht-Lundborg Disease: A Single-Centre Study","volume":"16","author":"Roivainen","year":"2014","journal-title":"Epileptic Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/epi.13662","article-title":"Perampanel in 12 Patients with Unverricht-Lundborg Disease","volume":"58","author":"Crespel","year":"2017","journal-title":"Epilepsia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.clinph.2021.07.006","article-title":"Marked Response to Perampanel: A Decade-Long Course of Giant Somatosensory Evoked Potentials in Unverricht-Lundborg Disease","volume":"132","author":"Tojima","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/epi.13275","article-title":"Brivaracetam in Unverricht-Lundborg Disease (EPM1): Results from Two Randomized, Double-Blind, Placebo-Controlled Studies","volume":"57","author":"Genton","year":"2016","journal-title":"Epilepsia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"106526","DOI":"10.1016\/j.eplepsyres.2020.106526","article-title":"Safety, Tolerability, and Efficacy of Brivaracetam as Adjunctive Therapy in Patients with Focal Seizures, Generalized Onset Seizures, or Unverricht\u2013Lundborg Disease: An Open-Label, Long-Term Follow-up Trial","volume":"170","author":"Baulac","year":"2021","journal-title":"Epilepsy Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-023-02880-6","article-title":"Prognostic Value of Pathogenic Variants in Lafora Disease: Systematic Review and Meta-Analysis of Patient-Level Data","volume":"18","author":"Pondrelli","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1093\/brain\/awab194","article-title":"Gys1 Antisense Therapy Rescues Neuropathological Bases of Murine Lafora Disease","volume":"144","author":"Ahonen","year":"2021","journal-title":"Brain"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s42466-019-0040-2","article-title":"Genotypes and Phenotypes of Patients with Lafora Disease Living in Germany","volume":"1","author":"Brenner","year":"2019","journal-title":"Neurol. Res. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"117409","DOI":"10.1016\/j.jns.2021.117409","article-title":"Italian Cohort of Lafora Disease: Clinical Features, Disease Evolution, and Genotype-Phenotype Correlations","volume":"424","author":"Riva","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1111\/epi.12806","article-title":"Mild Lafora Disease: Clinical, Neurophysiologic, and Genetic Findings","volume":"55","author":"Ferlazzo","year":"2014","journal-title":"Epilepsia"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s13023-021-01989-w","article-title":"Natural History of Lafora Disease: A Prognostic Systematic Review and Individual Participant Data Meta-Analysis","volume":"16","author":"Pondrelli","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2017.07.011","article-title":"A Novel EPM2A Mutation in a Patient with Lafora Disease Presenting with Early Parkinsonism Symptoms in Childhood","volume":"51","author":"Yildiz","year":"2017","journal-title":"Seizure"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.seizure.2021.06.002","article-title":"EPM2A In-Frame Deletion Slows Neurological Decline in Lafora Disease","volume":"91","author":"Lomax","year":"2021","journal-title":"Seizure"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41439-018-0015-9","article-title":"A Recurrent Homozygous NHLRC1 Variant in Siblings with Lafora Disease","volume":"5","author":"Araya","year":"2018","journal-title":"Hum. Genome Var."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e2228","DOI":"10.1002\/mgg3.2228","article-title":"MRI Characteristics Due to Gene Mutations in a Chinese Pedigree with Lafora Disease","volume":"11","author":"Sun","year":"2023","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1528-1167.2006.00526.x","article-title":"MRI Volumetry and Proton MR Spectroscopy of the Brain in Lafora Disease","volume":"47","author":"Villanueva","year":"2006","journal-title":"Epilepsia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1212\/WNL.0000000000005821","article-title":"Ocular Phenotype and Electroretinogram Abnormalities in Lafora Disease: A \u201cWindow to the Brain\u201d","volume":"91","author":"Vincent","year":"2018","journal-title":"Neurology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1007\/s00415-022-10974-7","article-title":"Ocular Phenotype and Electroretinogram Abnormalities in Lafora Disease and Correlation with Disease Stage","volume":"269","author":"Orsini","year":"2022","journal-title":"J. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Della Vecchia, S., Ogi, A., Licitra, R., Abramo, F., Nardi, G., Mero, S., Landi, S., Battini, R., Sicca, F., and Ratto, G.M. (2022). Trehalose Treatment in Zebrafish Model of Lafora Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126874"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.yebeh.2016.06.041","article-title":"Efficacy and Tolerability of Perampanel in Ten Patients with Lafora Disease","volume":"62","author":"Goldsmith","year":"2016","journal-title":"Epilepsy Behav."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.molmed.2011.02.005","article-title":"Impaired Autophagy: A Link between Neurodegenerative Diseases and Progressive Myoclonus Epilepsies","volume":"17","author":"Polajnar","year":"2011","journal-title":"Trends Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s12035-015-9091-8","article-title":"Pharmacological Interventions to Ameliorate Neuropathological Symptoms in a Mouse Model of Lafora Disease","volume":"53","author":"Berthier","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/WNR.0000000000000751","article-title":"4-Phenylbutyric Acid and Metformin Decrease Sensitivity to Pentylenetetrazol-Induced Seizures in a Malin Knockout Model of Lafora Disease","volume":"28","author":"Serratosa","year":"2017","journal-title":"Neuroreport"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Sanz, P., Serratosa, J.M., and S\u00e1nchez, M.P. (2021). Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22105351"},{"key":"ref_58","first-page":"291","article-title":"Enhanced Sensitivity of Laforin- and Malin-Deficient Mice to the Convulsant Agent Pentylenetetrazole","volume":"8","author":"Serratosa","year":"2014","journal-title":"Front. Neurosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13023-019-1132-3","article-title":"Treatment with Metformin in Twelve Patients with Lafora Disease","volume":"14","author":"Bisulli","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s12035-020-02170-3","article-title":"Trehalose Ameliorates Seizure Susceptibility in Lafora Disease Mouse Models by Suppressing Neuroinflammation and Endoplasmic Reticulum Stress","volume":"58","author":"Sinha","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"113656","DOI":"10.1016\/j.expneurol.2021.113656","article-title":"Dexamethasone-Induced Activation of Heat Shock Response Ameliorates Seizure Susceptibility and Neuroinflammation in Mouse Models of Lafora Disease","volume":"340","author":"Sinha","year":"2021","journal-title":"Exp. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1007\/s12035-021-02285-1","article-title":"Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model","volume":"58","author":"Heredia","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/epi.13656","article-title":"Sodium Selenate Treatment Improves Symptoms and Seizure Susceptibility in a Malin-Deficient Mouse Model of Lafora Disease","volume":"58","author":"Serratosa","year":"2017","journal-title":"Epilepsia"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cmet.2019.07.002","article-title":"Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion","volume":"30","author":"Brewer","year":"2019","journal-title":"Cell Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/hmg\/ddu024","article-title":"Glycogen Accumulation Underlies Neurodegeneration and Autophagy Impairment in Lafora Disease","volume":"23","author":"Duran","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Varea, O., Duran, J., Aguilera, M., Prats, N., and Guinovart, J.J. (2021). Suppression of Glycogen Synthesis as a Treatment for Lafora Disease: Establishing the Window of Opportunity. Neurobiol. Dis., 147.","DOI":"10.1016\/j.nbd.2020.105173"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2217\/nnm-2020-0477","article-title":"A Novel Gene Therapy for Neurodegenerative Lafora Disease via EPM2A-Loaded DLinDMA Lipoplexes","volume":"16","author":"Vemana","year":"2021","journal-title":"Nanomedicine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13023-022-02288-8","article-title":"Clinical and Genetic Characterization of a Cohort of 97 CLN6 Patients Tested at a Single Center","volume":"17","author":"Rus","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0883073813494268","article-title":"Classification and Natural History of the Neuronal Ceroid Lipofuscinoses","volume":"28","author":"Mink","year":"2013","journal-title":"J. Child. Neurol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Pati\u00f1o, L.C., Battu, R., Ortega-Recalde, O., Nallathambi, J., Anandula, V.R., Renukaradhya, U., and Laissue, P. (2014). Exome Sequencing Is an Efficient Tool for Variant Late-Infantile Neuronal Ceroid Lipofuscinosis Molecular Diagnosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109576"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/dmcn.12634","article-title":"Standardized Assessment of Seizures in Patients with Juvenile Neuronal Ceroid Lipofuscinosis","volume":"57","author":"Augustine","year":"2015","journal-title":"Dev. Med. Child. Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.0000000000001784","article-title":"Electroclinical Spectrum of the Neuronal Ceroid Lipofuscinoses Associated with CLN6 Mutations","volume":"85","author":"Canafoglia","year":"2015","journal-title":"Neurology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","article-title":"Therapeutic Landscape for Batten Disease: Current Treatments and Future Prospects","volume":"15","author":"Johnson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ebcr.2018.02.005","article-title":"Seizure Remission and Improvement of Neurological Function in Sialidosis with Perampanel Therapy","volume":"10","author":"Hu","year":"2018","journal-title":"Epilepsy Behav. Case Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1002\/mgg3.1316","article-title":"Genetic and Clinical Characterization of Mainland Chinese Patients with Sialidosis Type 1","volume":"8","author":"Han","year":"2020","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/tjo.tjo_53_17","article-title":"Optical Coherence Tomography Features in a Case of Type i Sialidosis","volume":"7","author":"Wang","year":"2017","journal-title":"Taiwan. J. Ophthalmol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Coppola, A., Ianniciello, M., Vanli-Yavuz, E.N., Rossi, S., Simonelli, F., Castellotti, B., Esposito, M., Tozza, S., Troisi, S., and Bellofatto, M. (2020). Diagnosis and Management of Type 1 Sialidosis: Clinical Insights from Long-Term Care of Four Unrelated Patients. Brain Sci., 10.","DOI":"10.3390\/brainsci10080506"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2169\/internalmedicine.52.8901","article-title":"Clinical and Serial MRI Findings of a Sialidosis Type I Patient with a Novel Missense Mutation in the NEU1 Gene","volume":"52","author":"Sekijima","year":"2013","journal-title":"Intern. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pediatrneurol.2020.03.004","article-title":"Reduction in Myoclonus and Ataxia Following the Use of Perampanel in Patient with Sialidosis Type 1","volume":"109","author":"So","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuroscience.2019.03.057","article-title":"Mechanisms of Neurological Dysfunction in GOSR2 Progressive Myoclonus Epilepsy, a Golgi SNAREopathy","volume":"420","author":"Jepson","year":"2019","journal-title":"Neuroscience"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awt021","article-title":"\u201cNorth Sea\u201d Progressive Myoclonus Epilepsy: Phenotype of Subjects with GOSR2 Mutation","volume":"136","author":"Bayly","year":"2013","journal-title":"Brain"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Hentrich, L., Parnes, M., Lotze, T.E., Coorg, R., de Koning, T.J., Nguyen, K.M., Yip, C.K., Jungbluth, H., Koy, A., and Dafsari, H.S. (2023). Novel Genetic and Phenotypic Expansion in GOSR2-Related Progressive Myoclonus Epilepsy. Genes, 14.","DOI":"10.3390\/genes14101860"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"104184","DOI":"10.1016\/j.ejmg.2021.104184","article-title":"Compound Heterozygous Variants in GOSR2 Associated with Congenital Muscular Dystrophy: A Case Report","volume":"64","author":"Henige","year":"2021","journal-title":"Eur. J. Med. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13395-018-0163-0","article-title":"TRAPPC11 and GOSR2 Mutations Associate with Hypoglycosylation of \u03b1-Dystroglycan and Muscular Dystrophy","volume":"8","author":"Larson","year":"2018","journal-title":"Skelet. Muscle"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/mdc3.12190","article-title":"Expanding the Phenotype and Genetic Defects Associated with the GOSR2 Gene","volume":"2","author":"Praschberger","year":"2015","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13023-017-0595-3","article-title":"The Efficacy of the Modified Atkins Diet in North Sea Progressive Myoclonus Epilepsy: An Observational Prospective Open-Label Study","volume":"12","author":"Weijenberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/mdc3.12372","article-title":"Deep Brain Stimulation in Three Related Cases of North Sea Progressive Myoclonic Epilepsy from South Africa","volume":"4","author":"Anderson","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kyriakou, K., Lederer, C.W., Kleanthous, M., Drousiotou, A., and Malekkou, A. (2020). Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051607"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13023-018-0845-z","article-title":"Acid Ceramidase Deficiency: Farber Disease and SMA-PME","volume":"13","author":"Yu","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13052-023-01474-z","article-title":"Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME): Three New Cases and Review of the Mutational Spectrum","volume":"49","author":"Najafi","year":"2023","journal-title":"Ital. J. Pediatr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.seizure.2016.09.007","article-title":"Eyelid Myoclonic Status Epilepticus: A Rare Phenotype in Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy Associated with ASAH1 Gene Mutation","volume":"42","author":"Tekturk","year":"2016","journal-title":"Seizure"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/acn3.51687","article-title":"The Clinical Spectrum of SMA-PME and in Vitro Normalization of Its Cellular Ceramide Profile","volume":"9","author":"Lee","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/epi.12977","article-title":"Spinal Muscular Atrophy Associated with Progressive Myoclonic Epilepsy: A Rare Condition Caused by Mutations in ASAH1","volume":"56","author":"Rubboli","year":"2015","journal-title":"Epilepsia"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Denard, J., Marinello, M., Latournerie, V., Bonnin, D., Derome, M., Martin, S., Medin, J., and Bello, A.B. (2022). Gene Therapy of Spinal Muscular Atrophy with Progressive Myoclonus Epilepsy (SMA-PME), Elsevier.","DOI":"10.1016\/j.nmd.2022.07.217"},{"key":"ref_95","unstructured":"(2023, December 23). Genethon Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME) and Farber\u2019s Disease. Available online: https:\/\/www.genethon.com\/our-pipeline\/spinal-muscular-atrophy-with-progressive-myoclonic-epilepsy-sma-pme-and-farbers-disease\/."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Kleynerman, A., Rybova, J., Faber, M.L., McKillop, W.M., Levade, T., and Medin, J.A. (2023). Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions. Biomolecules, 13.","DOI":"10.3390\/biom13020274"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.bbadis.2016.05.001","article-title":"Acid Ceramidase and the Treatment of Ceramide Diseases: The Expanding Role of Enzyme Replacement Therapy","volume":"1862","author":"Schuchman","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.bbamcr.2019.02.010","article-title":"Pathophysiological Characterization of MERRF Patient-Specific Induced Neurons Generated by Direct Reprogramming","volume":"1866","author":"Jackson","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.anorl.2018.10.015","article-title":"MERRF Syndrome (Myoclonic Epilepsy with Ragged Red Fibres) Presenting with Cervicothoracic Lipomatosis","volume":"136","author":"Hervochon","year":"2019","journal-title":"Eur. Ann. Otorhinolaryngol. Head. Neck Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1038\/s41467-018-06471-z","article-title":"RNA Modification Landscape of the Human Mitochondrial TRNALys Regulates Protein Synthesis","volume":"9","author":"Richter","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"\u0160tufkov\u00e1, H., Kol\u00e1\u0159ov\u00e1, H., Lokvencov\u00e1, K., Honz\u00edk, T., Zeman, J., Hans\u00edkov\u00e1, H., and Tesa\u0159ov\u00e1, M. (2022). A Novel MTTK Gene Variant m.8315A > C as a Cause of MERRF Syndrome. Genes, 13.","DOI":"10.3390\/genes13071245"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2169\/internalmedicine.7767-21","article-title":"Myoclonic Epilepsy with Ragged-Red Fibers with Intranuclear Inclusions","volume":"61","author":"Kawazoe","year":"2022","journal-title":"Intern. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s10020-022-00519-z","article-title":"Rapamycin Rescues Mitochondrial Dysfunction in Cells Carrying the m.8344A > G Mutation in the Mitochondrial TRNALys","volume":"28","author":"Capristo","year":"2022","journal-title":"Mol. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1093\/nar\/gkad139","article-title":"Restoration of Mitochondrial Function through Activation of Hypomodified TRNAs with Pathogenic Mutations Associated with Mitochondrial Diseases","volume":"51","author":"Tomoda","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Fabbri, A., Travaglione, S., Maroccia, Z., Guidotti, M., Pierri, C.L., Primiano, G., Servidei, S., Loizzo, S., and Fiorentini, C. (2018). The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19071825"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/hmg\/ddv619","article-title":"Short Peptides from Leucyl-TRNA Synthetase Rescue Disease-Causing Mitochondrial TRNA Point Mutations","volume":"25","author":"Perli","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1093\/nar\/gkab1112","article-title":"Database resources of the national center for biotechnology information","volume":"50","author":"Sayers","year":"2022","journal-title":"Nucleic. Acids Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ng.3144","article-title":"A Recurrent de Novo Mutation in KCNC1 Causes Progressive Myoclonus Epilepsy","volume":"47","author":"Muona","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/epi.16867","article-title":"Progressive Myoclonus Epilepsy KCNC1 Variant Causes a Developmental Dendritopathy","volume":"62","author":"Carpenter","year":"2021","journal-title":"Epilepsia"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/acn3.51707","article-title":"A KCNC1-Related Neurological Disorder Due to Gain of Kv3.1 Function","volume":"10","author":"Clatot","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.0000000000201722","article-title":"NEXMIF Epilepsy: An Alternative Cause of Progressive Myoclonus","volume":"100","author":"Chorny","year":"2023","journal-title":"Neurology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/acn3.51403","article-title":"Zonisamide-Responsive Myoclonus in SEMA6B-Associated Progressive Myoclonic Epilepsy","volume":"8","author":"Herzog","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"859183","DOI":"10.3389\/fped.2022.859183","article-title":"Non-Convulsive Status Epilepticus in SEMA6B-Related Progressive Myoclonic Epilepsy: A Case Report with Literature Review","volume":"10","author":"Duan","year":"2022","journal-title":"Front. Pediatr."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ajhg.2020.02.011","article-title":"De Novo Truncating Variants in the Last Exon of SEMA6B Cause Progressive Myoclonic Epilepsy","volume":"106","author":"Hamanaka","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1110310","DOI":"10.3389\/fgene.2023.1110310","article-title":"A Novel SEMA6B Variant Causes Adult-Onset Progressive Myoclonic Epilepsy-11 in a Chinese Family: A Case Report and Literature Review","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Genet."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1010150","DOI":"10.3389\/fneur.2022.1010150","article-title":"Adult-Onset Krabbe Disease Presenting with Progressive Myoclonic Epilepsy and Asymmetric Occipital Lesions: A Case Report","volume":"13","author":"Shang","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"E614","DOI":"10.1212\/NXG.0000000000000614","article-title":"Miglustat Therapy for SCARB2-Associated Action Myoclonus\u2013Renal Failure Syndrome","volume":"7","author":"Quraishi","year":"2021","journal-title":"Neurol. Genet."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Atasu, B., Acarl\u0131, A.N.O., Bilgic, B., Baykan, B., Demir, E., Ozluk, Y., Turkmen, A., Hauser, A.K., Guven, G., and Hanagasi, H. (2022). Genotype\u2013Phenotype Correlations of SCARB2 Associated Clinical Presentation: A Case Report and in-Depth Literature Review. BMC Neurol., 22.","DOI":"10.1186\/s12883-022-02628-y"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1007\/s10072-021-05196-0","article-title":"A Novel Homozygous Splice-Site Mutation in SCARB2 Is Associated with Progressive Myoclonic Epilepsy with Renal Failure","volume":"42","author":"Yari","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_120","first-page":"e13447","article-title":"A Novel Mutation in KCDT7 Gene in an Indian Girl with Progressive Myoclonus Epilepsy","volume":"13","author":"Dudipala","year":"2021","journal-title":"Cureus"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MCD.0000000000000394","article-title":"KCTD7-Related Progressive Myoclonic Epilepsy: Report of Three Indian Families and Review of Literature","volume":"31","author":"Narayanan","year":"2022","journal-title":"Clin. Dysmorphol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1111\/epi.12730","article-title":"Linkage Analysis and Exome Sequencing Identify a Novel Mutation in KCTD7 in Patients with Progressive Myoclonus Epilepsy with Ataxia","volume":"55","author":"Farhan","year":"2014","journal-title":"Epilepsia"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"106371","DOI":"10.1016\/j.eplepsyres.2020.106371","article-title":"NUS1 Mutation in a Family with Epilepsy, Cerebellar Ataxia, and Tremor","volume":"164","author":"Araki","year":"2020","journal-title":"Epilepsy Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5334\/tohm.696","article-title":"NUS1 and Epilepsy-Myoclonus-Ataxia Syndrome: An Under-Recognized Entity?","volume":"12","author":"Riboldi","year":"2022","journal-title":"Tremor Other Hyperkinetic Mov."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"113880","DOI":"10.1016\/j.expneurol.2021.113880","article-title":"Mutation of the Murine Prickle1 (R104Q) Causes Phenotypes Analogous to Human Symptoms of Epilepsy and Autism","volume":"347","author":"Ban","year":"2022","journal-title":"Exp. Neurol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.seizure.2019.04.016","article-title":"A Very Rare Form of Autosomal Dominant Progressive Myoclonus Epilepsy Caused by a Novel Variant in the PRICKLE1 Gene","volume":"69","author":"Algahtani","year":"2019","journal-title":"Seizure"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"fcab245","DOI":"10.1093\/braincomms\/fcab245","article-title":"Variants in ATP6V0A1 Cause Progressive Myoclonus Epilepsy and Developmental and Epileptic Encephalopathy","volume":"3","author":"Bott","year":"2021","journal-title":"Brain Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e04520","DOI":"10.1002\/ccr3.4520","article-title":"A Novel Biallelic LMNB2 Variant in a Patient with Progressive Myoclonus Epilepsy and Ataxia: A Case of Laminopathy","volume":"9","author":"Edizadeh","year":"2021","journal-title":"Clin. Case Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/acn3.51483","article-title":"Adult-Onset Rapidly Worsening Progressive Myoclonic Epilepsy Caused by a Novel Variant in DHDDS","volume":"8","author":"Kim","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"100401","DOI":"10.1016\/j.ebr.2020.100401","article-title":"Progressive Myoclonic Epilepsy\u2019-like Presentation of Cerebrotendinous Xanthomatosis in an Indian Family with A Novel C.646+1G>A Splice Site Mutation","volume":"15","author":"Desai","year":"2021","journal-title":"Epilepsy Behav. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e000180","DOI":"10.1136\/bmjno-2021-000180","article-title":"Progressive Myoclonic Epilepsy Due to Rare Mitochondrial ND6 Mutation, m.14487T>C","volume":"3","author":"Khoo","year":"2021","journal-title":"BMJ Neurol Open"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1212\/NXG.0000000000000593","article-title":"Migrating Focal Seizures and Myoclonic Status in ARV1-Related Encephalopathy","volume":"7","author":"Darra","year":"2021","journal-title":"Neurol. Genet."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ymgme.2020.10.010","article-title":"EEG Abnormalities in Patients with Chronic Neuronopathic Gaucher Disease: A Retrospective Review","volume":"131","author":"Poffenberger","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00415-018-9084-4","article-title":"Progressive Myoclonus Epilepsy in Gaucher Disease Due to a New Gly\u2013Gly Mutation Causing Loss of an Exonic Splicing Enhancer","volume":"266","author":"Tonin","year":"2019","journal-title":"J. Neurol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13052-020-00916-2","article-title":"Metreleptin for the Treatment of Progressive Encephalopathy with\/without Lipodystrophy (PELD) in a Child with Progressive Myoclonic Epilepsy: A Case Report","volume":"46","author":"Pedicelli","year":"2020","journal-title":"Ital. J. Pediatr."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2016.08.008","article-title":"Progressive Myoclonus Epilepsy in Congenital Generalized Lipodystrophy Type 2: Report of 3 Cases and Literature Review","volume":"42","author":"Opri","year":"2016","journal-title":"Seizure"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.seizure.2020.06.022","article-title":"Early-Onset Rapidly Progressive Myoclonic Epilepsy Associated with G392R Likely Pathogenic Variant in SERPINI1","volume":"80","author":"Kara","year":"2020","journal-title":"Seizure"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.seizure.2019.01.005","article-title":"Progressive Myoclonus Epilepsy Caused by a Gain-of-Function KCNA2 Mutation","volume":"65","author":"Canafoglia","year":"2019","journal-title":"Seizure"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.seizure.2018.12.021","article-title":"Compound Heterozygous SZT2 Mutations in Two Siblings with Early-Onset Epilepsy, Intellectual Disability and Macrocephaly","volume":"66","author":"Domingues","year":"2019","journal-title":"Seizure"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/mdc3.12610","article-title":"Progressive Myoclonic Epilepsy Type 8 Due to CERS1 Deficiency: A Novel Mutation with Prominent Ataxia","volume":"5","author":"Vale","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nbd.2017.07.006","article-title":"GPR37L1 Modulates Seizure Susceptibility: Evidence from Mouse Studies and Analyses of a Human GPR37L1 Variant","volume":"106","author":"Giddens","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_142","first-page":"156","article-title":"An Elongated Tract of PolyQ in the Carboxyl-Terminus of Human A1A Calcium Channel Induces Cell Apoptosis by Nuclear Translocation","volume":"44","author":"Sun","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.2147\/NDT.S145774","article-title":"Identification of a Novel CACNA1A Mutation in a Chinese Family with Autosomal Recessive Progressive Myoclonic Epilepsy","volume":"13","author":"Lv","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/0883073816643402","article-title":"Novel Compound Heterozygous Mutations Expand the Recognized Phenotypes of FARS2 -Linked Disease","volume":"31","author":"Walker","year":"2016","journal-title":"J. Child. Neurol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.seizure.2015.08.010","article-title":"GSTA1, GSTM1, GSTP1 and GSTT1 Polymorphisms in Progressive Myoclonus Epilepsy: A Serbian Case-Control Study","volume":"32","author":"Ercegovac","year":"2015","journal-title":"Seizure"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1212\/NXG.0000000000000083","article-title":"Progressive Myoclonus Epilepsy Associated with SACS Gene Mutations","volume":"2","author":"Nascimento","year":"2016","journal-title":"Neurol. Genet."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1111\/epi.17634","article-title":"IRF2BPL as a Novel Causative Gene for Progressive Myoclonus Epilepsy","volume":"64","author":"Gardella","year":"2023","journal-title":"Epilepsia"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1111\/epi.17557","article-title":"IRF2BPL: A New Genotype for Progressive Myoclonus Epilepsies","volume":"64","author":"Costa","year":"2023","journal-title":"Epilepsia"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Gumusgoz, E., Kasiri, S., Verma, M., Wu, J., Villarreal Acha, D., Marriam, U., Fyffe-Maricich, S., Lin, A., Chen, X., and Gray, S.J. (2023). CSTB Gene Replacement Improves Neuroinflammation, Neurodegeneration and Ataxia in Murine Type 1 Progressive Myoclonus Epilepsy. Gene Ther.","DOI":"10.1038\/s41434-023-00433-x"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/2\/171\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:50:29Z","timestamp":1760104229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/2\/171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,27]]},"references-count":149,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["genes15020171"],"URL":"https:\/\/doi.org\/10.3390\/genes15020171","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,27]]}}}